Sanofi China Chair Says Beijing Sending Good Message

The transcript discusses Xi Jinping's comments on trade openness amidst global trade tensions, highlighting China's openness to foreign investment, especially in pharmaceuticals. It explores the shift of global pharma innovation towards China, the implications of volume-based procurement, and the impact of vaccine scandals on local and international confidence.

In what ways could the proposed volume-based procurement affect drug quality and supply?

What measures are suggested to ensure the quality of vaccines in China?